Non-members left $300k of savings on the table in October alone.
As you’re well aware, the ongoing IV fluid shortage has been a headache of epic proportions for hospitals and surgery centers across the country. But what if I told you that InformIQ members have access to products AND at much better pricing than other secondary vendors, even during the crisis?
In October alone, non-members could have saved over $300,000 by leveraging InformIQ’s market intelligence and sourcing capabilities.
Why?
Because we don’t add markups and we take proactive steps to secure critical supplies at optimal prices in the midst of the chaos.
You see, InformIQ is more than just another vendor – we’re a strategic partner dedicated to keeping your operations running smoothly and your costs down, no matter what challenges arise. We’re the safety net you rely on in difficult times like this.
Unlike traditional warranty and insurance models, the risk is on us to prove our worth. In fact, we offer a money-back guarantee: If you don’t save more money than you invest in our program, we’ll refund the difference – Cash Money. We don’t just talk the talk – we quantify our impact and show you the results.
What did we do differently during the IV shortage?
First and foremost, we alerted our members that many of these products were short before the disruption, as we saw pricing and availability become more dynamic. Many of these generic fluids are predisposed to shortages for many reasons – we won’t go there, right now.
But we didn’t stop there. We also leveraged our vendor network, manufacturers and clients to stay informed on the latest developments, from the restart of the highest-throughput IV lines to the expanded expiration dates on existing products. This allowed us to strategically respond to our members needs with flexibility – including buying products on members’ behalf and giving them the option to take the fluids or wait for the allocation in their contracted pipeline.
While others were forced to go without fluids or pay exorbitant prices from secondary vendors, our members had the resources they needed. And that’s just the beginning. InformIQ’s comprehensive solution touches every aspect of your supply chain, optimizing efficiency, enhancing care provider morale, and improving patient outcomes.
Still not convinced? Let’s talk numbers.
Industry reports estimate that drug shortages are costing hospitals at least $359 million per year in additional labor costs alone. When you factor in the hidden impacts on patient safety and care quality, the true cost is astronomical.
We’re the antidote to that pain. We make the challenges easier to manage. With a clear ROI on the subscription, it’s a no-brainer investment that pays dividends both on your balance sheet and in your staff’s peace of mind.
The best part? We’re not for everyone. We partner with high-achieving, innovative organizations that understand the true cost of drug shortages and value true expertise. Is that you?
Set up time to chat with me.
If you’ll be in Chicago for the Becker’s Conferences – the CEO Roundtable and Chief Pharmacy Officer Summit next week, I’d love to chat about how InformIQ can be the strategic partner you’ve been searching for.
Don’t wait until the next shortage crisis hits. Secure your spot with InformIQ before our limited membership fills up.
Guiding you through every challenge,
Kenny
InformIQ Team
P.S. Remember, we don’t just talk about the problem – we provide proven solutions. If you went without critical fluids due to the disruption, you know the pain all too well. Let us be your reliable, transparent partner in weathering the next storm.
Works Cited: Matocha, Nancy. Drug shortages and labor costs: Measuring the hidden costs of drug shortages on U.S. hospitals. Vizient, n.d. https://wieck-vizient-production.s3.us-west-1.amazonaws.com/page-Brum/attachment/c9dba646f40b9b5def8032480ea51e1e85194129